Pint Pharma announces Orladeyo approval in Mexico for HAE prevention
Pint Pharma has announced that COFEPRIS in Mexico has approved ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema.
Pint Pharma has announced that COFEPRIS in Mexico has approved ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema.
What's Your Reaction?
